logo
Search orAI Icon𝛼SK
ENTITY

Cadrenal Therapeutics (CVKD US)

7
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
more
Company Event • 13 Mar 2026 04:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 10 Nov 2025 22:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 11 Aug 2025 19:00 • Upcoming
Add To Calendar

Q2 2025

Company Event • 09 May 2025 04:00 • Upcoming
Add To Calendar

Q1 2025

Company Event • 13 Mar 2025 21:30 • Upcoming
Add To Calendar

Q4 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x